SCHEMBL5772874

SCHEMBL5772874

Cc1nc(-c2ccc(Cl)cc2)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 4/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
POLB P06746 1/20 0.45
PKM P14618 1/20 0.45
RAB9A P51151 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
CTRC Q99895 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
TP53 P04637 2/20 0.43
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774390 0.84 KDM4E (0.59) KDM4EL3MBTL1LMNAHPGDSMN1; SMN2
SCHEMBL5774543 0.82 ADORA1 (0.48) KDM4EL3MBTL1HPGDSMN1; SMN2MAPT
SCHEMBL5772706 0.82 MEN1 (0.40) GAAMAPTALDH1A1MEN1KMT2A
SCHEMBL5773383 0.80 CXCL12 (0.41) LMNAHPGDSMN1; SMN2MAPTALDH1A1
SCHEMBL5776173 0.80 NPY5R (0.51) KDM4ELMNAHPGDSMN1; SMN2MAPT
SCHEMBL5775603 0.79 ADORA3 (0.50) KDM4EL3MBTL1HPGDSMN1; SMN2MAPT
SCHEMBL5777535 0.78 NPY5R (0.51) KDM4EHPGDSMN1; SMN2MAPTALDH1A1
SCHEMBL5772983 0.78 KDM4E (0.49) KDM4EHPGDSMN1; SMN2MAPTALDH1A1
SCHEMBL5796755 0.77 ADORA3 (0.43) KDM4EL3MBTL1HPGDSMN1; SMN2MAPT
SCHEMBL5771758 0.77 ADORA2A (0.48) KDM4EHPGDSMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed